|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Division of Pulmonary and Critical Care Medicine, University of Kansas School of Medicine, Kansas City, KS, and the Department of Medicine, Kansas City Veterans Affairs Medical Center, Kansas City, MO.
Purpose: Extracellular free iron, or iron bound to ferritin, may promote oxidative injury and bacterial growth in airways of patients with chronic airway inflammation due to cystic fibrosis (CF) or chronic bronchitis (CB). In this study, we assessed sputum content of total iron, ferritin, and transferrin in patients with CF or CB as well as sputum from normal subjects with acute airway inflammation caused by viral upper respiratory tract infections (URTIs).
Methods: Spontaneously produced sputum was obtained from 33 subjects, including 10 subjects with CF, 18 subjects with CB (10 acute exacerbations, 8 with stable CB), and 5 subjects with URTIs (control subjects). After lysing and dilution, total iron concentrations were determined by controlled coulometry, ferritin was measured by radioimmunoassay, and transferrin was measured by enzyme-linked immunosorbent assay.
Results: Iron was not present in detectable amounts in control sputums, but ferritin was present (6±2 ng/mg protein, mean±SE), as was transferrin (2.37±0.44 µg/mg). Compared with control subjects, concentrations of iron in sputum were increased in patient groups with higher amounts in CF patients (242±47 ng/mg, p<0.01) than CB patients with acute exacerbations or patients with stable CB (98±50 and 42±12 ng/mg, p<0.05 for both). Ferritin content of sputum was also increased in each group, with CF patients (113±22 ng/mg, p<0.001) higher than CB patients (acute, 45±10 ng/mg; stable, 87±24 ng/mg; p<0.01 for both). Compared with control subjects, sputum transferrin was decreased in CF patients (1.09±0.40 µg/mg, p<0.05), but not CB patients.
Conclusions: These findings indicate there are increased airway concentrations of total iron and ferritin-bound iron in patients with CB and, to a greater extent, in patients with CF. Particularly in CF patients who also demonstrated decreased airway concentrations of transferrin, ferritin-bound iron in airways may promote oxidative injury and enhance bacterial growth.
Key Words: chronic bronchitis cystic fibrosis ferritin iron sputum
Submitted on August 20, 1997
Accepted on March 2, 1998
This article has been cited by other articles:
![]() |
U. P. Kodavanti, M. C. Schladweiler, A. D. Ledbetter, R. V. Ortuno, M. Suffia, P. Evansky, J. H. Richards, R. H. Jaskot, R. Thomas, E. Karoly, et al. The Spontaneously Hypertensive Rat: An Experimental Model of Sulfur Dioxide-Induced Airways Disease Toxicol. Sci., November 1, 2006; 94(1): 193 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Whitby, T. M. VanWagoner, J. M. Springer, D. J. Morton, T. W. Seale, and T. L. Stull Burkholderia cenocepacia utilizes ferritin as an iron source J. Med. Microbiol., June 1, 2006; 55(6): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhou, F. Lu, C. Latham, D. S. Zander, and G. A. Visner Heme Oxygenase-1 Expression in Human Lungs with Cystic Fibrosis and Cytoprotective Effects against Pseudomonas Aeruginosa In Vitro Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 633 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.W. Reid, Q.T. Lam, H. Schneider, and E.H. Walters Airway iron and iron-regulatory cytokines in cystic fibrosis Eur. Respir. J., August 1, 2004; 24(2): 286 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Reid and S. M. Kirov Iron, Pseudomonas aeruginosa and cystic fibrosis Microbiology, March 1, 2004; 150(3): 516 - 516. [Full Text] [PDF] |
||||
![]() |
A.-P. Zeng and E.-J. Kim Iron availability, oxygen limitation, Pseudomonas aeruginosa and cystic fibrosis Microbiology, March 1, 2004; 150(3): 516 - 518. [Full Text] [PDF] |
||||
![]() |
A. J. Ghio, E. Nozik-Grayck, J. Turi, I. Jaspers, D. R. Mercatante, R. Kole, and C. A. Piantadosi Superoxide-Dependent Iron Uptake: A New Role for Anion Exchange Protein 2 Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 653 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yang, X. Wang, D. J. Haile, C. A. Piantadosi, and A. J. Ghio Iron increases expression of iron-export protein MTP1 in lung cells Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L932 - L939. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Reid, N. J. Withers, L. Francis, J. W. Wilson, and T. C. Kotsimbos Iron Deficiency in Cystic Fibrosis : Relationship to Lung Disease Severity and Chronic Pseudomonas aeruginosa Infection Chest, January 1, 2002; 121(1): 48 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. STITES, M. W. PLAUTZ, K. BAILEY, A. R. O'BRIEN-LADNER, and L. J. WESSELIUS Increased Concentrations of Iron and Isoferritins in the Lower Respiratory Tract of Patients with Stable Cystic Fibrosis Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 796 - 801. [Abstract] [Full Text] |
||||
![]() |
I. M. Smirnov, K. Bailey, C. H. Flowers, N. W. Garrigues, and L. J. Wesselius Effects of TNF-alpha and IL-1beta on iron metabolism by A549 cells and influence on cytotoxicity Am J Physiol Lung Cell Mol Physiol, August 1, 1999; 277(2): L257 - L263. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |